| Literature DB >> 29314654 |
Giulia Zucchetti1, Francesca Rossi2, Carolina Chamorro Vina3, Nicoletta Bertorello1, Franca Fagioli1.
Abstract
An exercise program (EP) during cancer treatment seems to be a valid strategy against physiological and quality-of-life impairments, but scientific evidence of benefits among pediatric patients is still limited. This review summarizes the literature focused on randomized controlled trials of EP offered to patients during leukemia and lymphoma treatment. Studies published up to June 2017 were selected from multiple databases and assessed by three independent reviewers for methodological validity. The review identified eight studies, but several types of bias have to be avoided to provide evidence-based recommendations accessible to patients, families, and professionals.Entities:
Keywords: exercise program; neurotoxicity of therapies; pediatric oncology; supportive care
Mesh:
Year: 2018 PMID: 29314654 DOI: 10.1002/pbc.26924
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN: 1545-5009 Impact factor: 3.167